Company profile: Aizon
1.1 - Company Overview
Company description
- Provider of a cloud-based AI SaaS platform that optimizes biotech and pharma manufacturing by integrating structured and unstructured data for advanced analytics, predictive insights, and real-time monitoring. Products include Aizon Predict, Aizon Unify, batch comparison analytics, real-time process monitoring, digital batch review, and consulting for AI adoption, AI model industrialization, and GMP-compliant data management.
Products and services
- Aizon Unify: A real-time production historian integrating manufacturing data to break down silos, enable continuous monitoring, and deliver actionable insights for biotech and pharma operations
- Aizon Predict: A cloud-based AI platform performing predictive analytics to optimize yields, reduce process deviations, and anticipate maintenance across manufacturing processes within biotech and pharma
- Digital Batch Review: A regulatory-focused application centralizing batch information to streamline batch release, accelerate regulatory reporting, and simplify Product Quality Review analyses for manufacturing operations
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Aizon
Enveda Biosciences
HQ: United States
Website
- Description: Provider of a drug discovery platform using machine learning, metabolomics, robotics, and the MS2Mol AI to index nature’s chemical space and predict structures from mass spectrometry, rapidly identifying small molecules; harnesses nature’s chemical diversity to deliver new medicines for complex diseases, novel modalities (protein degradation, stabilization, covalent inhibition), novel targets, and a pipeline in pain, dermatology, immunology, inflammation, and neuroinflammation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enveda Biosciences company profile →
Science 37
HQ: United States
Website
- Description: Provider of decentralized, virtual clinical trial solutions enabling universal participation by engaging patients from home. Offerings include Metasite to eliminate physical proximity barriers and allow participation from anywhere; centralized patient recruitment to confirm eligibility and consent; and remote trials connecting researchers with participants, with proven faster enrollment and higher patient retention.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Science 37 company profile →
Kayentis
HQ: France
Website
- Description: Provider of eCOA and Decentralized Clinical Trial solutions that streamline clinical trial data collection and quality for pharma, biotech, and CROs. Offers Clin'form platform, app, web portal, and Connect for at-home/on-site capture, multi-mode entry, real-time monitoring, interoperability with EDC/CDMS, and integration with medical devices and wearables, plus project and data management services. Active since 2005 across phases I–IV and 200+ indications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kayentis company profile →
Inova
HQ: France
Website
- Description: Provider of digital partnering solutions for the biopharma and life sciences industry, offering Inpart, a platform connecting academic researchers, universities and industry to facilitate collaboration and commercialization; Connect, an algorithm- and machine learning–based matchmaking platform aligning biotech assets with biopharma needs; Deal, a CRM for biopharma partnering; and Event, software for managing in-person or online life science conferences and meetings.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inova company profile →
Cellares
HQ: United States
Website
- Description: Provider of automated cell therapy manufacturing solutions, including the Cell Shuttle—a fully closed, high-throughput platform integrating all unit operations; Smart Factories for mass manufacturing; a Technology Adoption Program to automate and transfer developer processes; process and analytical development services; and clinical and commercial cGMP manufacturing through a global network of IDMO Smart Factories.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellares company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Aizon
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Aizon
2.2 - Growth funds investing in similar companies to Aizon
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Aizon
4.2 - Public trading comparable groups for Aizon
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →